Free Trial
→ Trump’s treachery (From Porter & Company) (Ad) Buy HSTM Stock  Free HSTM Stock Alerts

HealthStream (HSTM) Financials

HealthStream logo
$28.16 +0.10 (+0.34%)
As of 12:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for HealthStream

Annual Income Statements for HealthStream

This table shows HealthStream's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders		 20 15 12 5.85 14 16 32 10 3.76 8.62 10
Consolidated Net Income / (Loss)		 20 15 12 5.85 14 16 32 10 3.76 8.62 10
Net Income / (Loss) Continuing Operations		 20 15 12 5.85 14 14 13 8.84 4.79 8.62 10
Total Pre-Tax Income 		25 19 16 7.77 18 18 17 10 7.75 14 17
Total Operating Income		 21 16 12 8.06 16 15 15 9.41 7.17 14 16
Total Gross Profit		 194 184 176 166 155 150 136 128 117 120 97
Total Revenue		 292 279 267 257 245 254 232 215 192 209 171
Operating Revenue		 292 279 267 257 245 254 232 215 192 209 171
Total Cost of Revenue		 98 95 91 91 89 104 96 87 75 89 74
Operating Cost of Revenue		 98 95 91 91 89 104 96 87 75 89 74
Total Operating Expenses		 172 168 163 158 140 136 120 118 110 106 80
Selling, General & Admin Expense		 35 36 37 40 42 41 34 31 30 29 23
Marketing Expense		 47 46 44 39 35 38 36 39 35 36 30
Research & Development Expense		 49 46 44 42 32 29 26 24 24 24 16
Depreciation Expense		 41 41 38 37 30 28 24 24 20 17 11
Total Other Income / (Expense), net		 3.52 2.49 3.14 -0.29 2.01 3.21 1.08 0.73 0.58 0.16 0.15
Interest & Investment Income		 3.83 2.36 0.44 - - - - - - - -
Other Income / (Expense), net		 -0.32 0.14 2.69 -0.29 2.01 3.21 1.08 0.73 0.58 0.16 0.15
Income Tax Expense		 4.80 3.30 3.49 1.92 3.73 3.73 3.32 1.30 2.96 5.10 6.13
Basic Earnings per Share		 $0.66 $0.50 $0.39 $0.19 $0.44 $0.49 $1.00 $0.31 $0.12 $0.29 $0.38
Weighted Average Basic Shares Outstanding		 30.39M 30.57M 30.65M 31.53M 31.96M 32.37M 32.26M 31.86M 31.72M 30.06M 27.57M
Diluted Earnings per Share		 $0.66 $0.50 $0.39 $0.18 $0.44 $0.49 $1.00 $0.31 $0.12 $0.28 $0.37
Weighted Average Diluted Shares Outstanding		 30.54M 30.67M 30.72M 31.62M 31.99M 32.43M 32.34M 32.20M 32.07M 30.44M 28.02M
Weighted Average Basic & Diluted Shares Outstanding		 30.43M 30.30M 30.58M 30.94M 31.49M 32.38M 32.20M 32.30M 31.30M 29.70M 27.40M
Cash Dividends to Common per Share		 $0.11 $0.10 $0.00 $0.00 - - $1.00 - - - -

Quarterly Income Statements for HealthStream

This table shows HealthStream's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 4.89 5.73 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Consolidated Net Income / (Loss)		 4.89 5.73 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Net Income / (Loss) Continuing Operations		 4.89 5.73 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Total Pre-Tax Income 		5.48 7.48 5.30 6.54 5.42 5.45 4.50 3.14 3.27 4.93
Total Operating Income		 4.69 6.50 4.41 5.69 4.26 4.86 4.01 2.89 3.08 2.38
Total Gross Profit		 49 49 48 48 47 47 46 45 45 44
Total Revenue		 74 73 72 73 71 70 69 69 69 67
Operating Revenue		 74 73 72 73 71 70 69 69 69 67
Total Cost of Revenue		 25 24 24 25 24 24 24 24 24 23
Operating Cost of Revenue		 25 24 24 25 24 24 24 24 24 23
Total Operating Expenses		 44 42 43 42 42 42 42 42 42 42
Selling, General & Admin Expense		 8.81 8.46 9.56 8.31 8.44 9.30 9.06 8.87 9.01 9.10
Marketing Expense		 12 11 11 12 11 11 11 12 11 11
Research & Development Expense		 13 12 12 12 12 11 11 12 12 11
Depreciation Expense		 10 10 10 10 11 10 10 9.93 9.61 9.59
Total Other Income / (Expense), net		 0.79 0.98 0.89 0.85 1.16 0.59 0.49 0.25 0.19 2.54
Other Income / (Expense), net		 -3.04 0.98 0.89 0.85 -1.20 0.59 0.49 0.25 -0.25 2.54
Income Tax Expense		 0.59 1.75 1.13 1.32 0.83 1.59 0.37 0.52 0.82 1.26
Basic Earnings per Share		 $0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Weighted Average Basic Shares Outstanding		 30.39M 30.41M 30.40M 30.31M 30.57M 30.68M 30.68M 30.59M 30.65M 30.57M
Diluted Earnings per Share		 $0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Weighted Average Diluted Shares Outstanding		 30.54M 30.59M 30.53M 30.42M 30.67M 30.77M 30.78M 30.66M 30.72M 30.66M
Weighted Average Basic & Diluted Shares Outstanding		 30.43M 30.41M 30.41M 30.40M 30.30M 30.29M 30.69M 30.68M 30.58M 30.57M
Cash Dividends to Common per Share		 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 - $0.00

Annual Cash Flow Statements for HealthStream

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents		 19 -5.69 -0.88 10 -95 -2.78 50 35 -32 0.02 22
Net Cash From Operating Activities		 58 64 51 42 36 66 43 47 24 35 34
Net Cash From Continuing Operating Activities		 58 64 51 42 36 66 44 43 24 35 34
Net Income / (Loss) Continuing Operations		 20 15 12 5.85 14 14 13 8.84 4.79 8.62 10
Consolidated Net Income / (Loss)		 20 15 12 5.85 14 16 32 10 3.76 8.62 10
Depreciation Expense		 41 41 38 37 30 28 24 24 20 17 11
Amortization Expense		 12 11 11 9.17 8.77 8.31 7.66 - - - -
Non-Cash Adjustments To Reconcile Net Income		 5.66 4.24 1.07 5.40 -1.73 4.32 4.03 3.72 3.17 2.00 0.09
Changes in Operating Assets and Liabilities, net		 -22 -8.06 -11 -15 -15 11 -4.92 6.00 -4.44 7.30 13
Net Cash From Investing Activities		 -34 -57 -28 -26 -110 -68 37 -12 -57 -135 -16
Net Cash From Continuing Investing Activities		 -34 -57 -28 -26 -110 -68 37 -8.82 -56 -135 -16
Purchase of Property, Plant & Equipment		 -28 -28 -25 -25 -19 -37 -18 -15 -14 -15 -10
Acquisitions		 -1.30 -6.62 -3.97 -4.71 -121 -27 0.00 -0.50 -55 -89 -13
Purchase of Investments		 -74 -50 -13 -6.97 -62 -91 -58 -83 -107 -85 -45
Sale of Property, Plant & Equipment		 0.00 0.00 0.03 0.00 0.00 0.02 0.00 - 0.98 - -
Sale and/or Maturity of Investments		 70 28 14 11 92 81 69 90 119 55 53
Net Cash From Financing Activities		 -4.52 -13 -24 -6.21 -20 -0.92 -30 0.00 0.05 100 3.74
Net Cash From Continuing Financing Activities		 -4.52 -13 -24 -6.21 -20 -0.92 -30 0.00 0.05 100 3.74
Repayment of Debt		 0.00 -0.12 0.00 0.00 - - -0.10 - - -28 -
Repurchase of Common Equity		 0.00 -8.93 -23 -5.01 -20 0.00 0.00 - - - -
Payment of Dividends		 -3.40 -3.06 0.00 -0.02 -0.04 -0.10 -32 - - -0.63 -0.42
Other Financing Activities, net		 -1.11 -0.93 -0.57 -1.18 -0.44 -0.82 2.24 0.00 0.05 2.58 4.17
Effect of Exchange Rate Changes		 -0.04 -0.02 0.02 -0.11 0.06 - - - - - -
Cash Interest Paid		 0.10 0.13 0.10 0.13 0.10 0.10 0.12 0.10 0.08 0.19 0.06
Cash Income Taxes Paid		 8.70 2.61 0.72 -0.09 0.88 0.63 17 0.64 2.50 2.65 1.64

Quarterly Cash Flow Statements for HealthStream

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 1.98 11 -6.28 12 -3.79 18 -23 2.81 -2.23 11
Net Cash From Operating Activities		 11 19 6.45 21 14 25 4.95 21 8.11 15
Net Cash From Continuing Operating Activities		 11 19 6.45 21 14 25 4.95 21 8.11 15
Net Income / (Loss) Continuing Operations		 4.89 5.72 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Consolidated Net Income / (Loss)		 4.89 5.72 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Depreciation Expense		 10 10 10 10 11 10 10 9.93 9.61 9.59
Amortization Expense		 3.42 3.10 3.00 2.96 3.03 3.00 2.75 2.71 2.77 2.80
Non-Cash Adjustments To Reconcile Net Income		 1.40 0.97 2.37 0.92 0.81 1.13 1.11 1.20 1.03 -1.67
Changes in Operating Assets and Liabilities, net		 -9.01 -0.76 -13 1.50 -5.14 6.27 -13 4.08 -7.75 0.71
Net Cash From Investing Activities		 -8.07 -6.87 -12 -7.12 -9.38 -3.92 -26 -17 -10 -4.05
Net Cash From Continuing Investing Activities		 -8.07 -6.87 -12 -7.12 -9.38 -3.92 -26 -17 -10 -4.05
Purchase of Property, Plant & Equipment		 -6.84 -6.84 -6.71 -7.76 -6.60 -6.72 -6.25 -8.45 -6.14 -5.96
Acquisitions		 -1.30 - - 0.00 - - - -6.62 0.04 -
Purchase of Investments		 -23 -17 -20 -14 -12 -6.25 -29 -2.85 -7.87 -3.58
Sale and/or Maturity of Investments		 23 17 15 15 9.25 9.05 9.00 1.00 3.60 5.49
Net Cash From Financing Activities		 -1.03 -0.92 -0.86 -1.70 -8.27 -2.44 -1.54 -0.79 -0.05 -0.02
Net Cash From Continuing Financing Activities		 -1.03 -0.92 -0.86 -1.70 -8.27 -2.44 -1.54 -0.79 -0.05 -0.02
Payment of Dividends		 -0.85 -0.85 -0.85 -0.85 -0.76 -0.77 -1.53 0.00 - -
Other Financing Activities, net		 -0.18 -0.07 -0.01 -0.86 -0.12 -0.02 -0.01 -0.79 -0.05 -0.02
Effect of Exchange Rate Changes		 -0.08 0.04 0.04 -0.04 0.05 0.01 -0.06 -0.02 0.07 0.01

Annual Balance Sheets for HealthStream

This table presents HealthStream's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets		 511 500 498 487 500 442 411 396 380 257
Total Current Assets		 153 130 114 107 115 241 200 177 210 175
Cash & Equivalents		 59 40 46 47 37 134 85 50 82 82
Short-Term Investments		 38 31 7.89 5.04 9.93 34 46 54 67 39
Accounts Receivable		 35 38 43 35 46 41 38 47 36 33
Prepaid Expenses		 18 18 15 9.16 9.57 14 16 18 14 13
Other Current Assets		 2.47 3.03 2.65 11 13 18 8.33 8.69 8.17 5.77
Plant, Property, & Equipment, net		 11 13 15 18 22 16 8.09 10 12 9.44
Total Noncurrent Assets		 347 357 368 362 363 185 203 208 158 73
Goodwill		 191 191 192 183 178 86 86 110 83 42
Intangible Assets		 99 109 119 122 127 78 85 95 70 28
Other Noncurrent Operating Assets		 57 57 52 50 50 17 0.75 0.60 0.93 2.04
Total Liabilities & Shareholders' Equity		 511 500 498 487 500 442 411 396 380 257
Total Liabilities		 151 159 164 148 166 123 111 110 99 89
Total Current Liabilities		 116 118 117 100 119 107 101 95 89 77
Accounts Payable		 6.63 7.47 7.29 5.13 9.33 8.50 4.18 3.13 4.62 4.75
Accrued Expenses		 15 18 30 21 29 32 22 21 16 16
Current Deferred Revenue		 84 84 79 74 81 66 65 69 65 54
Current Employee Benefit Liabilities		 9.51 9.49 - - - - 2.76 1.99 3.31 2.31
Total Noncurrent Liabilities		 36 41 46 47 47 16 9.88 15 10 12
Noncurrent Deferred Revenue		 1.66 2.17 2.94 1.58 1.60 2.87 6.29 7.86 4.35 3.66
Noncurrent Deferred & Payable Income Tax Liabilities		 15 16 18 18 15 11 - 5.97 4.76 5.84
Other Noncurrent Operating Liabilities		 19 23 26 28 31 2.21 1.05 1.10 1.06 2.65
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 359 341 334 339 334 319 300 286 280 168
Total Preferred & Common Equity		 359 341 334 339 334 319 300 286 280 168
Preferred Stock		 0.00 0.00 - - - - - - - -
Total Common Equity		 359 341 334 339 334 319 300 286 280 168
Common Stock		 252 249 255 271 272 287 283 281 279 175
Retained Earnings		 109 92 80 68 62 32 18 5.35 1.59 -7.03
Accumulated Other Comprehensive Income / (Loss)		 -2.05 -0.69 -0.98 0.11 0.00 -0.02 -0.04 -0.05 -0.07 -0.04

Quarterly Balance Sheets for HealthStream

This table presents HealthStream's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 503 500 512 498 493 503 481
Total Current Assets		 146 139 147 127 118 125 104
Cash & Equivalents		 57 46 52 44 26 49 48
Short-Term Investments		 37 37 31 28 30 9.82 3.59
Accounts Receivable		 32 36 44 35 41 47 33
Prepaid Expenses		 16 17 18 11 9.88 11 9.26
Other Current Assets		 3.16 3.12 2.09 9.51 11 8.21 11
Plant, Property, & Equipment, net		 11 12 13 14 14 15 16
Total Noncurrent Assets		 346 349 352 358 361 363 361
Long-Term Investments		 3.98 4.05 4.10 4.19 4.28 4.39 4.64
Goodwill		 191 191 191 191 191 191 188
Intangible Assets		 100 103 106 111 114 118 117
Other Noncurrent Operating Assets		 51 51 51 51 51 50 51
Total Liabilities & Shareholders' Equity		 503 500 512 498 493 503 481
Total Liabilities		 147 150 167 156 153 167 151
Total Current Liabilities		 111 112 126 115 109 121 105
Accounts Payable		 4.44 5.81 5.31 3.52 22 20 22
Accrued Expenses		 23 19 22 28 5.24 6.53 5.61
Current Deferred Revenue		 83 87 98 83 82 94 78
Total Noncurrent Liabilities		 37 38 41 41 44 46 46
Capital Lease Obligations		 18 19 19 - - - -
Noncurrent Deferred Revenue		 1.67 1.89 2.08 2.74 2.26 2.56 1.26
Noncurrent Deferred & Payable Income Tax Liabilities		 15 16 17 15 17 19 19
Other Noncurrent Operating Liabilities		 1.99 2.22 2.25 23 24 25 26
Total Equity & Noncontrolling Interests		 355 349 345 342 341 336 330
Total Preferred & Common Equity		 355 349 345 342 341 336 330
Total Common Equity		 355 349 345 342 341 336 330
Common Stock		 251 250 249 255 256 255 254
Retained Earnings		 105 100 97 89 85 82 78
Accumulated Other Comprehensive Income / (Loss)		 -0.88 -1.22 -1.17 -1.24 -0.89 -1.02 -1.42

Annual Metrics And Ratios for HealthStream

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.51% 4.59% 3.94% 4.85% -3.65% 9.71% 7.78% 11.85% -8.08% 22.45% 29.04%
EBITDA Growth		 8.68% 7.92% 18.49% -5.34% 4.95% 11.63% 41.76% 21.58% -8.46% 11.89% 20.97%
EBIT Growth		 29.80% 6.70% 94.97% -56.43% -0.59% 8.17% 63.46% 30.81% -43.49% -16.96% 11.31%
NOPAT Growth		 30.43% 36.31% 59.31% -51.52% 7.30% -5.89% 51.05% 85.00% -47.98% -17.31% 23.85%
Net Income Growth		 31.51% 25.82% 106.86% -58.52% -10.65% -51.05% 222.04% 166.42% -56.44% -17.06% 23.47%
EPS Growth		 32.00% 28.21% 116.67% -59.09% -10.20% -51.00% 222.58% 158.33% -57.14% -24.32% 23.33%
Operating Cash Flow Growth		 -9.86% 24.97% 20.77% 18.15% -45.36% 51.82% -7.42% 92.75% -30.60% 1.93% 26.62%
Free Cash Flow Firm Growth		 28.50% 36.54% 107.98% 105.99% -3,841.91% -50.03% -87.29% 199.84% 35.80% -1,353.20% -8.50%
Invested Capital Growth		 -2.77% -2.18% -1.57% -0.25% 80.65% 5.89% 4.52% -21.85% 40.69% 182.92% 10.79%
Revenue Q/Q Growth		 1.27% 0.74% 1.60% 0.99% -0.36% 1.14% 2.01% 16.47% -13.89% 5.30% 5.10%
EBITDA Q/Q Growth		 -4.40% 1.42% 6.83% -0.73% -3.01% 2.88% 24.50% 7.37% -4.44% -1.13% 6.37%
EBIT Q/Q Growth		 -15.24% -1.27% 28.13% -17.39% -13.92% 1.92% 13.08% 5.88% -9.86% -13.86% 4.37%
NOPAT Q/Q Growth		 3.34% 11.04% 38.42% -17.47% -14.06% 6.10% -4.89% 36.77% -18.61% -9.77% 9.55%
Net Income Q/Q Growth		 1.51% 16.38% 30.64% -18.31% -16.38% 6.00% -3.47% 74.16% -36.12% -8.82% 9.33%
EPS Q/Q Growth		 1.54% 16.28% 34.48% -21.74% -18.52% 8.89% -2.91% 72.22% -33.33% -15.15% 12.12%
Operating Cash Flow Q/Q Growth		 -4.40% 9.79% 4.40% 1.99% -18.21% -1.99% 8.52% 4.00% -0.60% 12.27% 5.34%
Free Cash Flow Firm Q/Q Growth		 196.57% -1.14% 116.51% 107.83% -954.31% 155.44% -86.12% 136.75% -1.57% 2.61% 87.88%
Invested Capital Q/Q Growth		 -4.52% 1.27% 0.67% 2.46% 56.22% 0.61% 6.32% -16.67% -1.58% -1.99% 0.70%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 66.42% 65.95% 65.84% 64.54% 63.51% 59.12% 58.55% 59.42% 60.98% 57.23% 56.56%
EBITDA Margin		 25.61% 24.63% 23.87% 20.94% 23.19% 21.29% 20.92% 15.91% 14.64% 14.70% 16.08%
Operating Margin		 7.30% 5.74% 4.67% 3.14% 6.46% 5.79% 6.69% 4.38% 3.73% 6.49% 9.59%
EBIT Margin		 7.19% 5.79% 5.67% 3.03% 7.28% 7.06% 7.16% 4.72% 4.03% 6.56% 9.68%
Profit (Net Income) Margin		 6.86% 5.45% 4.53% 2.28% 5.76% 6.21% 13.91% 4.66% 1.95% 4.12% 6.09%
Tax Burden Percent		 80.66% 82.18% 77.58% 75.26% 79.06% 87.96% 194.37% 98.66% 48.44% 62.84% 62.91%
Interest Burden Percent		 118.28% 114.58% 102.93% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 19.34% 17.82% 22.42% 24.74% 20.94% 20.82% 20.05% 12.84% 38.20% 37.16% 37.09%
Return on Invested Capital (ROIC)		 6.46% 4.83% 3.48% 2.16% 5.74% 7.71% 8.63% 5.12% 2.88% 9.86% 23.99%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.09% 1.67% -0.67% 2.55% 8.84% -41.27% -3.32% 3.77% 3.41% 9.78% 23.91%
Return on Net Nonoperating Assets (RNNOA)		 -0.74% -0.32% 0.12% -0.43% 2.70% 2.17% 1.78% -1.71% -1.56% -6.01% -17.44%
Return on Equity (ROE)		 5.72% 4.51% 3.59% 1.74% 8.44% 9.89% 10.41% 3.41% 1.33% 3.85% 6.55%
Cash Return on Invested Capital (CROIC)		 9.27% 7.04% 5.06% 2.41% -51.74% 2.00% 4.20% 29.65% -30.93% -85.68% 13.76%
Operating Return on Assets (OROA)		 4.15% 3.24% 3.08% 1.57% 3.60% 3.85% 3.89% 2.51% 2.00% 4.31% 7.03%
Return on Assets (ROA)		 3.96% 3.05% 2.46% 1.18% 2.85% 3.39% 7.55% 2.48% 0.97% 2.71% 4.42%
Return on Common Equity (ROCE)		 5.72% 4.51% 3.59% 1.74% 8.44% 9.89% 10.41% 3.41% 1.33% 3.85% 6.55%
Return on Equity Simple (ROE_SIMPLE)		 5.57% 4.46% 3.62% 1.72% 4.22% 0.00% 10.10% 3.33% 1.31% 3.08% 6.19%
Net Operating Profit after Tax (NOPAT)		 17 13 9.66 6.06 13 12 12 8.20 4.43 8.52 10
NOPAT Margin		 5.89% 4.72% 3.62% 2.36% 5.11% 4.59% 5.35% 3.82% 2.31% 4.08% 6.04%
Net Nonoperating Expense Percent (NNEP)		 3.37% 3.16% 4.14% -0.39% -3.11% 48.98% 11.95% 1.36% -0.52% 0.07% 0.08%
Return On Investment Capital (ROIC_SIMPLE)		 4.78% 3.86% 2.89% - - - - - - - -
Cost of Revenue to Revenue		 33.58% 34.05% 34.16% 35.46% 36.49% 40.88% 41.45% 40.58% 39.02% 42.77% 43.44%
SG&A Expenses to Revenue		 12.05% 12.78% 13.82% 15.46% 17.11% 15.97% 14.87% 14.65% 15.85% 14.00% 13.42%
R&D to Revenue		 16.76% 16.32% 16.59% 16.23% 13.20% 11.46% 11.11% 11.24% 12.61% 11.59% 9.65%
Operating Expenses to Revenue		 59.12% 60.21% 61.18% 61.40% 57.05% 53.32% 51.86% 55.04% 57.25% 50.75% 46.97%
Earnings before Interest and Taxes (EBIT)		 21 16 15 7.77 18 18 17 10 7.75 14 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 75 69 64 54 57 54 48 34 28 31 27
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.69 2.39 2.26 2.44 2.06 2.59 2.43 2.34 2.65 2.37 4.62
Price to Tangible Book Value (P/TBV)		 13.97 20.03 32.76 23.67 24.29 5.66 5.00 5.43 9.27 5.21 7.88
Price to Revenue (P/Rev)		 3.32 2.92 2.82 3.22 2.81 3.44 3.35 3.27 3.94 3.17 4.55
Price to Earnings (P/E)		 48.34 53.60 62.31 141.33 48.75 55.45 24.06 70.33 201.66 76.91 74.65
Dividend Yield		 0.43% 0.37% 0.00% 0.00% 0.00% 0.00% 4.17% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.07% 1.87% 1.61% 0.71% 2.05% 1.80% 4.16% 1.42% 0.50% 1.30% 1.34%
Enterprise Value to Invested Capital (EV/IC)		 3.32 2.76 2.52 2.74 2.26 4.47 4.11 4.05 3.62 4.00 14.47
Enterprise Value to Revenue (EV/Rev)		 2.98 2.67 2.60 2.99 2.59 2.73 2.60 2.65 3.39 2.44 3.83
Enterprise Value to EBITDA (EV/EBITDA)		 11.65 10.83 10.91 14.27 11.16 12.84 12.44 16.63 23.15 16.62 23.79
Enterprise Value to EBIT (EV/EBIT)		 41.49 46.07 45.90 98.78 35.55 38.75 36.38 56.08 83.95 37.21 39.54
Enterprise Value to NOPAT (EV/NOPAT)		 50.67 56.53 71.95 126.53 50.67 59.61 48.69 69.36 146.84 59.92 63.40
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.09 11.63 13.58 18.10 17.66 10.58 13.94 12.17 26.85 14.62 19.07
Enterprise Value to Free Cash Flow (EV/FCFF)		 35.29 38.79 49.46 113.55 0.00 230.44 99.93 11.98 0.00 0.00 110.55
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.24 -0.19 -0.17 -0.17 0.31 -0.05 -0.54 -0.45 -0.46 -0.61 -0.73
Leverage Ratio		 1.44 1.48 1.46 1.47 2.96 2.92 1.38 1.38 1.37 1.42 1.48
Compound Leverage Factor		 1.71 1.69 1.51 1.47 2.96 2.92 1.38 1.38 1.37 1.42 1.48
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.93 4.03 3.62 4.15 3.25 0.00 4.90 4.76 4.95 5.07 6.50
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.32 1.10 0.98 1.06 0.96 2.14 2.26 1.98 1.87 2.35 2.26
Quick Ratio		 1.15 0.93 0.82 0.87 0.78 1.93 1.96 1.67 1.59 2.10 2.02
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 25 19 14 6.76 -113 3.02 6.03 47 -48 -74 5.91
Operating Cash Flow to CapEx		 204.89% 228.42% 204.13% 167.23% 190.79% 179.91% 234.40% 309.11% 189.18% 227.34% 335.78%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.58 0.56 0.54 0.52 0.49 0.55 0.54 0.53 0.50 0.66 0.73
Accounts Receivable Turnover		 7.91 6.88 6.87 6.34 6.40 7.12 5.86 5.03 4.59 6.01 5.84
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 24.56 19.59 15.96 12.78 0.00 0.00 19.34 23.44 16.92 19.08 18.47
Accounts Payable Turnover		 13.90 12.88 14.69 12.59 0.00 0.00 15.15 23.88 19.36 19.08 20.99
Days Sales Outstanding (DSO)		 46.16 53.07 53.10 57.60 57.01 51.26 62.26 72.53 79.54 60.70 62.53
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 26.26 28.33 24.86 28.99 0.00 0.00 24.09 15.29 18.85 19.13 17.39
Cash Conversion Cycle (CCC)		 19.90 24.74 28.24 28.61 57.01 51.26 38.17 57.24 60.69 41.57 45.14
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 262 270 276 280 281 155 147 140 180 128 45
Invested Capital Turnover		 1.10 1.02 0.96 0.92 1.12 1.68 1.61 1.34 1.25 2.42 3.98
Increase / (Decrease) in Invested Capital		 -7.48 -6.02 -4.39 -0.69 125 8.64 6.35 -39 52 83 4.39
Enterprise Value (EV)		 870 744 695 767 634 695 603 569 651 510 653
Market Capitalization		 967 815 753 826 687 874 775 704 757 663 776
Book Value per Share		 $11.82 $11.25 $10.93 $10.74 $10.55 $0.00 $9.87 $9.41 $9.01 $8.86 $6.07
Tangible Book Value per Share		 $2.28 $1.34 $0.75 $1.11 $0.89 $0.00 $4.80 $4.06 $2.57 $4.02 $3.56
Total Capital		 359 341 334 339 334 0.00 319 300 286 280 168
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -97 -71 -58 -59 -53 -180 -172 -135 -106 -153 -123
Capital Expenditures (CapEx)		 28 28 25 25 19 36 18 15 13 15 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -60 -59 -57 -45 -51 -53 -34 -32 -21 -29 -24
Debt-free Net Working Capital (DFNWC)		 37 12 -2.84 6.50 -4.72 119 135 99 82 120 97
Net Working Capital (NWC)		 37 12 -2.84 6.50 -4.72 119 135 99 82 120 97
Net Nonoperating Expense (NNE)		 -2.84 -2.05 -2.43 0.22 -1.59 -4.11 -20 -1.80 0.68 -0.10 -0.09
Net Nonoperating Obligations (NNO)		 -97 -71 -58 -59 -53 155 -172 -160 -106 -153 -123
Total Depreciation and Amortization (D&A)		 54 53 49 46 39 36 32 24 20 17 11
Debt-free, Cash-free Net Working Capital to Revenue		 -20.50% -21.24% -21.27% -17.71% -20.92% -21.05% -14.78% -15.10% -10.78% -13.65% -13.84%
Debt-free Net Working Capital to Revenue		 12.83% 4.25% -1.06% 2.53% -1.93% 46.98% 58.10% 45.91% 42.92% 57.64% 57.03%
Net Working Capital to Revenue		 12.83% 4.25% -1.06% 2.53% -1.93% 46.98% 58.10% 45.91% 42.92% 57.64% 57.03%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.66 $0.50 $0.39 $0.19 $0.44 $0.49 $1.00 $0.31 $0.12 $0.29 $0.38
Adjusted Weighted Average Basic Shares Outstanding		 30.39M 30.57M 30.65M 31.53M 31.96M 32.37M 32.26M 31.86M 31.72M 30.06M 27.57M
Adjusted Diluted Earnings per Share		 $0.66 $0.50 $0.39 $0.18 $0.44 $0.49 $1.00 $0.31 $0.12 $0.28 $0.37
Adjusted Weighted Average Diluted Shares Outstanding		 30.54M 30.67M 30.72M 31.62M 31.99M 32.43M 32.34M 32.20M 32.07M 30.44M 28.02M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 30.43M 30.30M 30.58M 30.94M 31.49M 32.38M 32.33M 32.04M 31.78M 31.65M 27.68M
Normalized Net Operating Profit after Tax (NOPAT)		 17 13 9.66 6.06 13 12 12 8.20 4.43 8.52 10
Normalized NOPAT Margin		 5.89% 4.72% 3.62% 2.36% 5.11% 4.59% 5.35% 3.82% 2.31% 4.08% 6.04%
Pre Tax Income Margin		 8.50% 6.63% 5.84% 3.03% 7.28% 7.06% 7.16% 4.72% 4.03% 6.56% 9.68%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 17.01% 20.10% 0.00% 0.33% 0.28% 0.61% 100.55% 0.00% 0.00% 7.34% 4.08%
Augmented Payout Ratio		 17.01% 78.79% 191.36% 86.01% 142.35% 0.61% 100.55% 0.00% 0.00% 7.34% 4.08%

Quarterly Metrics And Ratios for HealthStream

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 5.18% 3.92% 3.41% 5.53% 2.98% 4.54% 5.42% 5.48% 6.53% 4.98%
EBITDA Growth		 -6.52% 9.53% 6.84% 25.71% 9.24% 8.92% 12.03% 1.37% 36.53% 30.99%
EBIT Growth		 -46.19% 37.15% 17.78% 108.31% 8.35% 10.72% 23.90% -16.44% 666.13% 192.11%
NOPAT Growth		 15.88% 44.23% -5.77% 88.28% 56.38% 94.50% 46.86% -22.26% 814.80% 11.65%
Net Income Growth		 6.47% 48.05% 0.85% 99.28% 87.42% 5.48% 34.06% -9.33% 732.82% 144.40%
EPS Growth		 6.67% 46.15% 7.69% 88.89% 87.50% 8.33% 30.00% 0.00% 500.00% 140.00%
Operating Cash Flow Growth		 -19.20% -22.53% 30.38% 1.93% 70.35% 63.38% -32.46% -0.55% 36.29% 24.66%
Free Cash Flow Firm Growth		 21.14% -130.28% -39.74% 739.23% 43.70% 755.87% 315.33% -102.67% 1,708.98% 101.40%
Invested Capital Growth		 -2.77% 3.12% 0.20% 1.31% -2.18% -2.76% -0.41% 0.95% -1.57% 0.18%
Revenue Q/Q Growth		 1.56% 2.15% -1.65% 3.09% 0.34% 1.65% 0.37% 0.60% 1.86% 2.51%
EBITDA Q/Q Growth		 -24.81% 10.64% -5.88% 4.56% -11.89% 7.92% 10.74% 0.81% -12.16% 11.01%
EBIT Q/Q Growth		 -77.98% 41.11% -19.00% 20.79% -43.87% 21.18% 43.27% -3.92% -42.64% 35.60%
NOPAT Q/Q Growth		 -15.97% 43.39% -23.69% 26.02% 4.60% -6.32% 52.48% 4.66% 30.09% -29.26%
Net Income Q/Q Growth		 -14.64% 37.36% -20.26% 13.88% 18.70% -6.44% 57.57% 7.10% -33.20% 18.91%
EPS Q/Q Growth		 -15.79% 35.71% -17.65% 13.33% 15.38% 0.00% 44.44% 12.50% -33.33% 20.00%
Operating Cash Flow Q/Q Growth		 -41.60% 196.25% -69.19% 51.59% -44.01% 398.57% -75.91% 153.34% -46.30% 106.10%
Free Cash Flow Firm Q/Q Growth		 450.19% -214.55% 197.66% 115.05% -12.48% 127.99% 3,257.75% -102.28% 421.26% 157.36%
Invested Capital Q/Q Growth		 -4.52% -2.28% 1.58% -3.21% 1.27% -5.04% 2.71% -0.96% 0.67% -2.75%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 66.17% 66.52% 66.83% 66.17% 65.98% 66.47% 65.94% 65.40% 65.66% 65.26%
EBITDA Margin		 20.92% 28.26% 26.09% 27.26% 23.54% 26.81% 25.25% 22.89% 22.19% 25.73%
Operating Margin		 6.32% 8.89% 6.16% 7.82% 6.03% 6.91% 5.79% 4.19% 4.49% 3.54%
EBIT Margin		 2.22% 10.23% 7.41% 8.99% 4.34% 7.75% 6.50% 4.56% 4.12% 7.32%
Profit (Net Income) Margin		 6.58% 7.83% 5.82% 7.18% 6.50% 5.50% 5.97% 3.80% 3.57% 5.45%
Tax Burden Percent		 89.16% 76.55% 78.64% 79.89% 84.73% 70.92% 91.84% 83.51% 74.92% 74.44%
Interest Burden Percent		 332.79% 100.00% 100.00% 100.00% 176.97% 100.00% 100.00% 100.00% 115.72% 100.00%
Effective Tax Rate		 10.84% 23.45% 21.36% 20.11% 15.27% 29.08% 8.16% 16.49% 25.08% 25.56%
Return on Invested Capital (ROIC)		 6.18% 7.25% 4.93% 6.43% 5.23% 5.03% 5.19% 3.48% 3.23% 2.53%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.34% 6.29% 3.84% 5.39% 3.71% 4.40% 4.33% 3.12% 2.99% -0.49%
Return on Net Nonoperating Assets (RNNOA)		 -1.28% -1.41% -0.72% -1.04% -0.71% -0.87% -0.68% -0.55% -0.52% 0.09%
Return on Equity (ROE)		 4.89% 5.83% 4.21% 5.39% 4.52% 4.16% 4.50% 2.94% 2.71% 2.62%
Cash Return on Invested Capital (CROIC)		 9.27% 3.07% 5.18% 4.27% 7.04% 7.19% 3.98% 2.34% 5.06% 2.37%
Operating Return on Assets (OROA)		 1.28% 5.89% 4.26% 5.01% 2.43% 4.39% 3.67% 2.50% 2.23% 3.94%
Return on Assets (ROA)		 3.80% 4.51% 3.35% 4.01% 3.64% 3.11% 3.37% 2.08% 1.94% 2.93%
Return on Common Equity (ROCE)		 4.89% 5.83% 4.21% 5.39% 4.52% 4.16% 4.50% 2.94% 2.71% 2.62%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 5.54% 5.11% 5.17% 0.00% 3.82% 3.78% 3.52% 0.00% 2.80%
Net Operating Profit after Tax (NOPAT)		 4.18 4.97 3.47 4.55 3.61 3.45 3.68 2.41 2.31 1.77
NOPAT Margin		 5.63% 6.80% 4.85% 6.25% 5.11% 4.90% 5.32% 3.50% 3.37% 2.64%
Net Nonoperating Expense Percent (NNEP)		 0.84% 0.96% 1.09% 1.04% 1.52% 0.63% 0.86% 0.36% 0.24% 3.02%
Return On Investment Capital (ROIC_SIMPLE)		 1.16% - - - 1.06% - - - 0.69% -
Cost of Revenue to Revenue		 33.83% 33.48% 33.17% 33.83% 34.02% 33.53% 34.06% 34.60% 34.34% 34.74%
SG&A Expenses to Revenue		 11.86% 11.57% 13.35% 11.42% 11.96% 13.21% 13.10% 12.86% 13.14% 13.52%
R&D to Revenue		 17.08% 16.55% 16.88% 16.54% 16.90% 15.50% 15.94% 16.94% 17.23% 17.06%
Operating Expenses to Revenue		 59.86% 57.63% 60.66% 58.35% 59.95% 59.55% 60.15% 61.21% 61.16% 61.72%
Earnings before Interest and Taxes (EBIT)		 1.65 7.48 5.30 6.54 3.06 5.45 4.50 3.14 2.83 4.93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 16 21 19 20 17 19 17 16 15 17
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.69 2.47 2.43 2.34 2.39 1.93 2.20 2.45 2.26 1.95
Price to Tangible Book Value (P/TBV)		 13.97 13.72 15.26 16.71 20.03 16.52 21.45 30.07 32.76 25.96
Price to Revenue (P/Rev)		 3.32 3.05 2.97 2.85 2.92 2.38 2.74 3.04 2.82 2.46
Price to Earnings (P/E)		 48.34 44.49 47.46 45.23 53.60 50.46 58.25 69.61 62.31 69.73
Dividend Yield		 0.43% 0.46% 0.47% 0.48% 0.37% 0.35% 0.20% 0.00% 0.00% 0.00%
Earnings Yield		 2.07% 2.25% 2.11% 2.21% 1.87% 1.98% 1.72% 1.44% 1.61% 1.43%
Enterprise Value to Invested Capital (EV/IC)		 3.32 2.90 2.77 2.67 2.76 2.19 2.46 2.78 2.52 2.15
Enterprise Value to Revenue (EV/Rev)		 2.98 2.76 2.73 2.61 2.67 2.11 2.52 2.81 2.60 2.24
Enterprise Value to EBITDA (EV/EBITDA)		 11.65 10.19 10.21 9.82 10.83 8.61 10.41 11.81 10.91 9.88
Enterprise Value to EBIT (EV/EBIT)		 41.49 32.18 34.30 33.66 46.07 35.66 43.54 50.77 45.90 49.83
Enterprise Value to NOPAT (EV/NOPAT)		 50.67 47.91 51.57 48.20 56.53 49.22 68.63 85.10 71.95 84.39
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.09 13.20 11.83 11.46 11.63 10.02 14.16 14.88 13.58 12.01
Enterprise Value to Free Cash Flow (EV/FCFF)		 35.29 95.77 53.56 62.87 38.79 30.07 61.62 119.44 49.46 90.74
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.05 0.05 0.06 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.05 0.05 0.06 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.24 -0.22 -0.19 -0.19 -0.19 -0.20 -0.16 -0.17 -0.17 -0.19
Leverage Ratio		 1.44 1.43 1.44 1.49 1.48 1.46 1.46 1.50 1.46 1.45
Compound Leverage Factor		 4.80 1.43 1.44 1.49 2.62 1.46 1.46 1.50 1.69 1.45
Debt to Total Capital		 0.00% 4.81% 5.10% 5.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 4.81% 5.10% 5.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 95.19% 94.90% 94.65% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.23 0.25 0.26 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 -1.04 -0.89 -0.91 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.23 0.25 0.26 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 1.08 1.24 1.27 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 -4.87 -4.52 -4.46 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 1.08 1.24 1.27 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.80 4.57 4.33 3.81 3.94 3.41 3.79 3.75 3.54 3.37
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.32 1.32 1.24 1.17 1.10 1.11 1.08 1.03 0.98 0.99
Quick Ratio		 1.15 1.14 1.07 1.01 0.93 0.93 0.89 0.88 0.82 0.80
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 12 -3.33 2.91 0.98 9.63 11 4.82 -0.15 6.70 1.29
Operating Cash Flow to CapEx		 163.23% 279.44% 96.21% 269.78% 209.27% 367.37% 79.22% 243.23% 132.05% 253.17%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.58 0.58 0.57 0.56 0.56 0.57 0.56 0.55 0.54 0.54
Accounts Receivable Turnover		 7.91 8.66 7.40 6.19 6.88 8.21 7.23 6.14 6.87 8.28
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 24.56 23.39 21.66 20.78 19.59 18.98 17.71 17.03 15.96 15.45
Accounts Payable Turnover		 13.90 24.32 6.87 7.53 12.88 7.35 4.66 4.91 14.69 4.09
Days Sales Outstanding (DSO)		 46.16 42.13 49.31 58.93 53.07 44.45 50.48 59.44 53.10 44.07
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 26.26 15.01 53.16 48.46 28.33 49.64 78.35 74.36 24.86 89.32
Cash Conversion Cycle (CCC)		 19.90 27.12 -3.85 10.47 24.74 -5.18 -27.87 -14.91 28.24 -45.25
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 262 275 281 277 270 266 280 273 276 274
Invested Capital Turnover		 1.10 1.07 1.02 1.03 1.02 1.03 0.98 1.00 0.96 0.96
Increase / (Decrease) in Invested Capital		 -7.48 8.30 0.56 3.57 -6.02 -7.55 -1.14 2.57 -4.39 0.49
Enterprise Value (EV)		 870 796 779 738 744 584 689 760 695 589
Market Capitalization		 967 877 847 806 815 660 750 823 753 645
Book Value per Share		 $11.82 $11.69 $11.49 $11.38 $11.25 $11.15 $11.10 $10.99 $10.93 $10.80
Tangible Book Value per Share		 $2.28 $2.10 $1.83 $1.59 $1.34 $1.30 $1.14 $0.90 $0.75 $0.81
Total Capital		 359 373 368 364 341 342 341 336 334 330
Total Debt		 0.00 18 19 19 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 18 19 19 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -97 -81 -68 -68 -71 -76 -60 -63 -58 -56
Capital Expenditures (CapEx)		 6.84 6.84 6.71 7.76 6.60 6.72 6.25 8.45 6.14 5.96
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -60 -60 -56 -62 -59 -60 -47 -55 -57 -53
Debt-free Net Working Capital (DFNWC)		 37 35 27 21 12 12 8.86 4.10 -2.84 -1.04
Net Working Capital (NWC)		 37 35 27 21 12 12 8.86 4.10 -2.84 -1.04
Net Nonoperating Expense (NNE)		 -0.71 -0.75 -0.70 -0.68 -0.98 -0.42 -0.45 -0.21 -0.14 -1.89
Net Nonoperating Obligations (NNO)		 -97 -81 -68 -68 -71 -76 -60 -63 -58 -56
Total Depreciation and Amortization (D&A)		 14 13 13 13 14 13 13 13 12 12
Debt-free, Cash-free Net Working Capital to Revenue		 -20.50% -20.77% -19.55% -22.04% -21.24% -21.48% -17.19% -20.17% -21.27% -20.14%
Debt-free Net Working Capital to Revenue		 12.83% 12.18% 9.55% 7.54% 4.25% 4.44% 3.23% 1.52% -1.06% -0.40%
Net Working Capital to Revenue		 12.83% 12.18% 9.55% 7.54% 4.25% 4.44% 3.23% 1.52% -1.06% -0.40%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Adjusted Weighted Average Basic Shares Outstanding		 30.39M 30.41M 30.40M 30.31M 30.57M 30.68M 30.68M 30.59M 30.65M 30.57M
Adjusted Diluted Earnings per Share		 $0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Adjusted Weighted Average Diluted Shares Outstanding		 30.54M 30.59M 30.53M 30.42M 30.67M 30.77M 30.78M 30.66M 30.72M 30.66M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 30.43M 30.41M 30.41M 30.40M 30.30M 30.29M 30.69M 30.68M 30.58M 30.57M
Normalized Net Operating Profit after Tax (NOPAT)		 4.18 4.97 3.47 4.55 3.61 3.45 3.68 2.41 2.31 1.77
Normalized NOPAT Margin		 5.63% 6.80% 4.85% 6.25% 5.11% 4.90% 5.32% 3.50% 3.37% 2.64%
Pre Tax Income Margin		 7.38% 10.23% 7.41% 8.99% 7.68% 7.75% 6.50% 4.56% 4.77% 7.32%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 17.01% 16.78% 18.06% 21.93% 20.10% 17.60% 11.92% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 17.01% 53.72% 18.06% 21.93% 78.79% 30.21% 11.92% 0.00% 191.36% 304.11%

Frequently Asked Questions About HealthStream's Financials

When does HealthStream's financial year end?

According to the most recent income statement we have on file, HealthStream's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has HealthStream's net income changed over the last 10 years?

HealthStream's net income appears to be on an upward trend, with a most recent value of $20.01 million in 2024, rising from $10.39 million in 2014. The previous period was $15.21 million in 2023. See where experts think HealthStream is headed by visiting HealthStream's forecast page.

What is HealthStream's operating income?
HealthStream's total operating income in 2024 was $21.29 million, based on the following breakdown:
  • Total Gross Profit: $193.71 million
  • Total Operating Expenses: $172.42 million
How has HealthStream revenue changed over the last 10 years?

Over the last 10 years, HealthStream's total revenue changed from $170.69 million in 2014 to $291.65 million in 2024, a change of 70.9%.

How much debt does HealthStream have?

HealthStream's total liabilities were at $151.41 million at the end of 2024, a 4.9% decrease from 2023, and a 69.4% increase since 2014.

How much cash does HealthStream have?

In the past 9 years, HealthStream's cash and equivalents has ranged from $36.57 million in 2020 to $134.32 million in 2018, and is currently $59.47 million as of their latest financial filing in 2024.

How has HealthStream's book value per share changed over the last 10 years?

Over the last 10 years, HealthStream's book value per share changed from 6.07 in 2014 to 11.82 in 2024, a change of 94.5%.


Related Companies

This page (NASDAQ:HSTM) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
As Bitcoin supply vanishes, this Trump-aligned token could explode
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored